Patel concurs and adds that every once in a while people who use his low-dosage (100 or 175 milligrams) topical treatment will experience a minor rash that quickly dissipates. These individuals should lower the dose to better suit their needs, he advises
Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial
HSAN1 is extremely rare neurodegenerative disease caused by mutations that lead to misfolding, impaired nuclear localization, and early degradation of DNMT1
Design Randomised, double-blind, placebo-controlled - people were assigned by chance, neither side knew who got what, and one group got an inactive look-alike
Integrating Remote Weight Monitoring into Chronic Care Management (CCM) Given the overlapping nature of obesity, diabetes, and other chronic conditions, the synergy between remote weight monitoring and chronic care management (CCM) can significantly amplify patient outcomes
If pregnancy occurs during treatment, the medication should be stopped immediately and healthcare providers notified